Feasibility of glioblastoma tissue response mapping with physiologic BOLD imaging using precise oxygen and carbon dioxide challenge
Vittorio Stumpo(University of Zurich), Jorn Fierstra(University of Zurich), Martina Sebök(University of Zurich), Michael Weller(University Hospital of Zurich), Luca Regli(University of Zurich), Katharina Seystahl(University of Zurich), Nicolin Hainc(University of Zurich), Zsolt Kulcsár(University of Zurich), Christiaan Hendrik Bas van Niftrik(University of Zurich)
Magnetic Resonance Materials in Physics Biology and Medicine
December 7, 2021
Cited by 12
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
|The Lancet Oncology|2017|1.1k
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
|The Lancet Oncology|2017|1.1k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994